维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Betebenner"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Discovery and preclini- cal profile of saxagliptin ( BMS - 477118 ) : a highly potent, long- acting, orally active dipeptidyl peptidase IV inhibitor for the treat- ment of type 2 diabetes显示文摘	Auqer DJ Rob1 JA Betebenner DA	2005	J Med Chem2005，48，15：	1
2	Discoveryand preclinical profile of saxagliptin ( BMS-477118) : A highly po-tent, long-acting, orally active dipeptidyl peptidase IV inhibitorfor the treatment of type 2 diabetes 显示文摘	AUGERI D J ROBL J A BETEBENNER D A	2005	J Med Chem2005，48，15：	1
3	Discovery and pre- clinical profile of Saxagliptin ( BMS-477118 ) : a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘	Auqer DJ Robl JA Betebenner DA	2005	J Med Chem2005，48，15：	1
4	Discovery and preclinical profile of saxagliptin(BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘	Augeri D J Robl J A Betebenner D A	2005	J Med Chem2005，48，15：	1
5	Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘	Augeri D J Robl JA Betebenner DA	2005	J Med Chem2005，48，15：	1
6	Discovery and preclinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes显示文摘	Augeri D J Robl J A Betebenner D A		0，，15：	1
7	Discovery and preclinicalprofile of Saxagliptin(BMS-477118): a highly potent, long-acting, orallyactive dipeptidyl peptidase IV inhibitor for the treatment of type 2diabetes显示文摘	Augeri DJ Robl JA Betebenner DA	2005	Journal of Medicinal Chemistry2005，48，15：	1
8	Synthesis and structure-activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378(Lopinavir)显示文摘	SHAM H L BETEBENNER D A CHEN B		0，，：	1
9	Discovery and preclinical profile of Saxagliptin (BMS-477118) : a highly potent, long-acting, orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes显示文摘	AUGERI DJ ROBL JA BETEBENNER DA	2005	J Med Chem2005，48，15：	1
10	Discovery of pyridopyrimidine-based inhibitors of HCV NS5A 显示文摘	Degoey DA Betebenner DA Grampovnik DJ	2013	Bioorg Med Chem Lett2013，23，：	1
11	Discovery and preclinical profile of Saxagliptin(BMS-477118):a highly potent,long-acting,orally active dipeptidy1 peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘	AUGERI DJ ROBL JA BETEBENNER DA	2005	J Med Chem2005，48，15：	1
12	Discovery and pre-clinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidaseIVinhibitor for the treatment of type 2 diabetes 显示文摘	Augeri DJ Robl JA Betebenner DA	2005	J Med Chem2005，48，15：	1
13	Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378(Lopinavir)显示文摘	Sham HL Betebenner DA Herrin T	2001	Bioorg Med Chem Lett2001，11，：	1
14	Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘	Augeri DJ Robl JA Betebenner DA	2005	J Med Chem2005，48，15：	1
15	Discovery and preclinical profile of saxagliptin ( BMS-477118 ) : a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treat- ment of type 2 diabetes 显示文摘	AUGERI D J ROBL J A BETEBENNER D A	2005	J Med Chem2005，48，15：	1
16	Discovery and preclinieal profile of Saxagliptin ( BMS-477118 ) : a highly potent, long-acting, orally active dipeptidyl pepti- dase IV inhibitor for the treatment of type 2 diabetes 显示文摘	Augeri DJ Robl JA Betebenner DA	2005	J Med Chem2005，48，15：	1
17	Discovery and preclinical profile of saxagliptin( BMS-477118 ) : a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treat- ment of type 2 diabetes 显示文摘	AUGER/ D J ROBL J A BETEBENNER D A et tl	2005	J Med Chem2005，48，15：	1
18	Discovery and preclinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes显示文摘	Augeri D J Robl JA Betebenner DA		0，，15：	1
19	Discovery and preclinicaI profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘	Augeri D J Robl JA Betebenner DA et ai	2005	J Med Chem2005，48，15：	1
20	Discovery and preclinical profile of saxagliptin(BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidaseⅣinhibitor for the treatment of type 2 diabetes显示文摘	Augeri DJ Robl JA Betebenner DA	2005	J Med Chem2005，48，15：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示